Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06551142
Title A Study of GSK5764227 in Participants With Advanced Solid Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | CAN | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Denver Colorado 80218 United States Details
GSK Investigational Site New Haven Connecticut 06511 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Rosario S2002 Argentina Details
GSK Investigational Site Viedma R8500ACE Argentina Details
GSK Investigational Site Montreal H4A 3J1 Canada Details
GSK Investigational Site Ottawa K1H 8L6 Canada Details
GSK Investigational Site Sherbrooke J1H 5N4 Canada Details
GSK Investigational Site Toronto M5G 1X6 Canada Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Lyon cedex 08 69373 France Details
GSK Investigational Site Milano 20141 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Roma 00168 Italy Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site Glasgow G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field